Pasqualina Santaguida

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves et al. · BMJ · 2016 · 19K citations · Full text

Public Health, Biostatistics, Health Services Research +15

Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program

Rongwei Fu, Gerald Gartlehner, Mark D Grant et al. · Journal of Clinical Epidemiology · 2011 · 736 citations

Pharmacy, Health Policy, Health Services Administration +14

PRISMA harms checklist: improving harms reporting in systematic reviews

Liliane Zorzela, Yoon K. Loke, John P. A. Ioannidis et al. · BMJ · 2016 · 555 citations · Full text

Public Affairs, Preventive Medicine, Good Clinical Practice +11

Current Pharmacologic Treatment of Dementia: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians

Amir Qaseem, Vincenza Snow, J. Thomas Cross et al. · Annals of Internal Medicine · 2008 · 350 citations

Medicine, Pharmacology, Pharmacotherapy +16

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

Daniela R. Junqueira, Liliane Zorzela, Su Golder et al. · BMJ · 2023 · 249 citations · Full text

Pharmacy, Pharmacoeconomics, Clinical Epidemiology +16